Publicacións en colaboración con investigadores/as de Hospital Clinic Barcelona (36)

2023

  1. Economic evaluation of restrictive vs. liberal transfusion strategy following acute myocardial infarction (REALITY): trial-based cost-effectiveness and cost-utility analyses

    European heart journal. Quality of care & clinical outcomes, Vol. 9, Núm. 2, pp. 194-202

2021

  1. A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure

    Frontiers in Physiology, Vol. 12

  2. Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events among Patients with Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial

    JAMA - Journal of the American Medical Association, Vol. 325, Núm. 6, pp. 552-560

  3. Mural Endocarditis: The GAMES Registry Series and Review of the Literature

    Infectious Diseases and Therapy, Vol. 10, Núm. 4, pp. 2749-2764

2020

  1. Prevalence, clinical profile and prognostic implications of interatrial block in patients admitted for heart failure

    REC: CardioClinics, Vol. 55, Núm. 3, pp. 155-164

  2. Reducing residual thrombotic risk in patients with peripheral artery disease: Impact of the COMPASS trial

    Drugs in Context, Vol. 9

  3. Residual risk reduction opportunities in patients with chronic coronary syndrome. Role of dual pathway inhibition

    Expert Review of Clinical Pharmacology, Vol. 13, Núm. 7, pp. 695-706

2019

  1. Mitral valve repair in infective endocarditis is not inferior to valve replacement: results from a Spanish nationwide prospective registry

    General Thoracic and Cardiovascular Surgery, Vol. 67, Núm. 7, pp. 585-593

  2. Role of age and comorbidities in mortality of patients with infective endocarditis

    European Journal of Internal Medicine, Vol. 64, pp. 63-71

2018

  1. Long-term prognosis of patients with life-threatening ventricular arrhythmias induced by coronary artery spasm

    Europace, Vol. 20, Núm. 5, pp. 851-858

2016

  1. Consideraciones clínicas sobre la posología de los anticoagulantes orales de acción directa

    Revista Clinica Espanola

  2. Epicardial mapping and ablation of the right ventricle substrate during flecainide testing in Brugada syndrome

    HeartRhythm Case Reports, Vol. 2, Núm. 1, pp. 52-56

2015

  1. Clinical Practice Guideline (CPG). Recommendations on strategy for reducing risk of heart failure patients requiring noncardiac surgery: Reducing risk of heart failure patients in noncardiac surgery

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 62, Núm. 7, pp. 359-419

  2. Introduction of Innovations in Heart Disease in Spain: InnovaSEC

    Revista Espanola de Cardiologia, Vol. 68, Núm. 10, pp. 834-837

2014

  1. Validación de EuroSCORE II en España

    Cirugia Cardiovascular, Vol. 21, Núm. 4, pp. 246-251

2013

  1. Differential clinical characteristics and prognosis of intraventricular conduction defects in patients with chronic heart failure

    European Journal of Heart Failure, Vol. 15, Núm. 8, pp. 877-884

  2. El autocontrol de la terapia con cumarínicos es más eficiente que dabigatrán para prevenir ictus en fibrilación auricular no valvular en España. Respuesta

    Revista Espanola de Cardiologia

  3. In-hospital and mid-term predictors of mortality after transcatheter aortic valve implantation: Data from the Tavi national registry 2010-2011

    Revista Espanola de Cardiologia, Vol. 66, Núm. 12, pp. 949-958

2012

  1. Análisis coste-efectividad de dabigatrán para la prevención de ictus y embolia sistémica en fibrilación auricular no valvular en España

    Revista Espanola de Cardiologia, Vol. 65, Núm. 10, pp. 901-910

  2. Increased expression of fatty-acid and calcium metabolism genes in failing human heart

    PLoS ONE, Vol. 7, Núm. 6